3/14/2014 11:45 AM ET|
Just say no to pot stocks
As legalization of marijuana expands, companies linked to the drug are getting lots of attention. But most are iffy stocks not worthy of your investment.
Not long ago, merely mentioning the idea of investing in marijuana stocks would likely have elicited a question about what you had been smoking. But now Colorado and Washington state have legalized marijuana for recreational use, and pot stocks are on fire. But that doesn't mean you should join the party.
There are dozens of reasons why companies that hope to capitalize on the budding legality of marijuana are likely to face hurdles. The most significant is the complex legal landscape.
The federal government considers cannabis a banned substance but says that states can decriminalize the drug as long as they set up a legal structure. That has prompted two states -- Colorado and Washington -- to allow recreational use of marijuana and 18 additional states and Washington, D.C., to allow medical use. However, each state has a different set of rules -- and more than half consider all marijuana use a crime.
Banks, uncertain of how to deal with the legal ambiguities, have been unwilling to do business with the companies -- neither lending to them nor allowing them to open checking accounts. U.S. Attorney General Eric Holder recently vowed to set up a legal framework that will allow banks to open accounts for legal marijuana operators. For now, the lack of banking access creates an operating challenge.
Legalities aside, investing in industries in their infancy is almost always a dicey proposition. Consider personal computers. Although the industry soared at the outset, the top players from 30 years ago, Osborne and Commodore, are long defunct.
And unlike computers, which require technical expertise and patents, the barriers to entry into the pot business are far lower. That could lead to a raft of new competitors when the legal issues are settled.
Indeed, Morningstar analyst Thomas Mullarkey says that if marijuana were legalized nationwide, it would make sense for big tobacco companies to enter the market, vastly increasing the competition and likely driving down prices.
Already, even the top players in the cannabis industry are losing bushels of money. "These companies are financial train wrecks," says Peter Leeds, an expert on the penny-stock market, where many pot stocks trade. "They have tens of millions in debt, and they have no way to repay it."
Of the roughly 50 publicly traded companies with a pot connection, Leeds says, just two are worth considering: GW Pharmaceuticals (GWPH) and GrowLife (PHOT). But because their shares shot into the stratosphere after the Colorado legalization bill passed last year, he wouldn't buy either of them at their current prices. If the market were to cool down, they'd be stocks worth watching.
GW Pharmaceuticals, based in London, has received approval to sell cannabis-derived treatments overseas for both multiple sclerosis and epilepsy, and the company is seeking approval from the U.S. Food and Drug Administration to sell its drugs here. GW lost $7 million on $44 million in revenues in 2013. Its stock, which languished below $9 during most of 2013, now trades at $83.
GrowLife has focused on hydroponic growing systems and indoor lights, often used to cultivate medical marijuana. Shares of the Carson, Calif., company, which sold for 4 cents last year, now fetch 55 cents.
GrowLife reported $2.9 million in revenues and a $4.6 million loss during the first nine months of 2013. Although the stock's market value of $388 million is not inconsequential, a share price in pennies suggests an even greater level of risk in an already risky area.
More from Kiplinger
VIDEO ON MSN MONEY
Those that insist marijuana remain illegal are harboring a delusion at best. As if remaining illegal means anything at all regarding availability. All the "illegal" status means is many more lives will be ground up in the gears of the criminal justice system, nothing more. It has been said that the laws against marijuana have done exponentially more harm to people than the marijuana itself.
Eventually, marijuana will become a commodity like any other crop.
People that think that this thing is big are delusional (kind of like a pot head) #1, all the dummies pay the ridiculus prices plus tax, they will
realize (when they come out of thier marijuana fog) that they can buy the **** from the old pushers who are supplied by those wonderful Mexican cartels, you know, the guys who kill 50-100 people a day down south.
#2 This will be the biggest boon to the cartels because they can set thier price just below the legal stuff and make tons more money. What are they going to do? put serial # on maraju****aves? How ****ing stupid!
Copyright © 2014 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
[BRIEFING.COM] The stock market finished a down week on a cautious note with small caps leading the retreat. The Russell 2000 lost 0.5%, widening its weekly decline to 2.6%, while the S&P 500 shed 0.3%. The benchmark index ended the week lower by 2.7%.
This morning, the market was provided a basis to rebound with the July employment report, which was just right for the policy doves (209K versus Briefing.com consensus 220K). It showed payroll growth that was weaker than expected, ... More
More Market News
|There’s a problem getting this information right now. Please try again later.|
MUST-SEE ON MSN
- Video: Easy DIY smoked meats at home
A charcuterie master shares his process for cold-smoking meat at home.
- Jetpacks about to go mainstream
- Weird things covered by home insurance
- Bing: 70 percent of adults report 'digital eye strain'